カテゴリー： 世界, 医療/バイオ, visiongain

世界の神経刺激装置市場2023年～2033年

【英語タイトル】Neurostimulation Devices Market Report 2023-2033 : Forecasts by Product (Deep Brain Stimulator, Gastric Electric Stimulator, Spinal Cord Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Transcutaneous Electrical Nerve Stimulation (TENS), Others), by Application (Pain Management, Epilepsy, Essential Tremor, Urinary and Faecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis

visiongainが出版した調査資料（VGA23FB013）・商品コード：VGA23FB013
・発行会社（調査会社）：visiongain
・発行日：2022年12月16日
・ページ数：250
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後24時間以内）
・調査対象地域：グローバル
・産業分野：医薬品
◆販売価格オプション（消費税別）
Sigle User（1名様閲覧用、1年間、印刷不可）GBP3,950 ⇒換算￥750,500見積依頼/購入/質問フォーム
Enterprise（法人閲覧用、1年間、印刷可）GBP6,950 ⇒換算￥1,320,500見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Visiongain社の本調査レポートでは、世界の神経刺激装置市場規模が2033年までに年平均11.35%で成長すると予測しています。本レポートは、神経刺激装置の世界市場を徹底調査し、レポート概要、エグゼクティブサマリー、市場動向、製品別（DBS、GES、SCS、仙骨神経刺激装置、その他）分析、用途別（疼痛管理、てんかん、本態性振戦、尿失禁＆便失禁、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、企業情報などの内容を作成しました。本書には、Abbott Laboratories 、Boston Scientific Corporation、ElectroCore Inc. 、Helbling Holding AG 、Innovative Health Solutions, Inc. 、LivaNova PLC 、Medtronic 、MicroTransponder 、Neuronetics, Inc. 、Parasym Ltd.、Synapse Biomedical Inc、tVNS Technologies GmbH (Cerbomed)などの企業情報が含まれています。
・レポート概要
・エグゼクティブサマリー
・市場動向
・世界の神経刺激装置市場規模：製品別
- DBSの市場規模
- GESの市場規模
- SCSの市場規模
- 仙骨神経刺激装置の市場規模
- その他製品の市場規模
・世界の神経刺激装置市場規模：用途別
- 疼痛管理用神経刺激装置の市場規模
- てんかん用神経刺激装置の市場規模
- 本態性振戦用神経刺激装置の市場規模
- 尿失禁＆便失禁用神経刺激装置の市場規模
- その他用途の市場規模
・世界の神経刺激装置市場規模：地域別
- 北米の神経刺激装置市場規模
- ヨーロッパの神経刺激装置市場規模
- アジア太平洋の神経刺激装置市場規模
- 中南米の神経刺激装置市場規模
- 中東・アフリカの神経刺激装置市場規模
・企業情報

The Neurostimulation Devices Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Favourable Regulatory and Reimbursement Scenario will Accelerate Neurostimulation Devices Market Growth
Presence of regulatory bodies such as MHRA and NICE for clinical and safety guidelines and enabling regulatory approval of neurostimulation devices under Class III devices will favour industry growth in the future. Growing focus of regulatory authorities in addressing the need for effective drug development for neurological disorders will accelerate business growth. For instance, Stimwave Technologies was granted the authorization to decide on the reimbursement with healthcare insurers over and above of the DRG payment limits for its chronic pain management products.

Complications Associated with Usage of Neurostimulation Devices
The complications in neurostimulation devices are majorly categorized into hardware complications, biological complications, and programming or therapy-related complications. Some of the hardware-related complications include battery depletion, flipping, lead migration, and recharging difficulties. Biological complications include the pain related to device components, wound infections, skin erosion, complications related to device removal, and accidental dural puncture. Programming related complications include loss of paranesthesia or painful paranesthesia. Complications related to programming are not very frequent, however it could result in device removal due to therapy failure. These aforementioned complications act as challenges in the adoption of neurostimulation devices, thereby restraining the growth of the market.

Lack of Skilled Healthcare Practitioners
The inadequate number of healthcare practitioners with the required skills to manage and treat neurological diseases will hamper industry growth over the coming years. Treatment and assessment are required to support diagnosis in a few cases. In most of cases, individual test results need to be interpreted carefully that requires skilled expertise. In most of the low and middle-income countries, access to healthcare services is challenging due to financial constraints, there is a shortage of skilled nurses and doctors, neurologists are rare, and neurological diagnostic services are not present. Even when neurological diseases are diagnosed, lack of patient information, and usage of traditional medicine delay the initiation of treatment.

What Questions Should You Ask before Buying a Market Research Report?
• How is the Neurostimulation Devices Market evolving?
• What is driving and restraining the Neurostimulation Devices Market?
• How will each Neurostimulation Devices submarket grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each Neurostimulation Devices submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading Neurostimulation Devices Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the neurostimulation devices development projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of neurostimulation devices development projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the Neurostimulation Devices Market?
• Where is the Neurostimulation Devices Market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Neurostimulation Devices Market today, and over the next 10 years:
• Our 250-page report provides 111 tables and 139 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Neurostimulation Devices Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising neurostimulation devices prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

By Product
• Deep Brain Stimulator
• Gastric Electric Stimulator
• Spinal Cord Stimulator
• Sacral Nerve Stimulator
• Vagus Nerve Stimulator
• Transcutaneous Electrical Nerve Stimulation
• Others

By Application
• Pain Management
• Epilepsy
• Essential Tremor
• Urinary and Fecal Incontinence
• Depression
• Dystonia
• Gastroparesis
• Parkinson’s Disease
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 16 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Neurostimulation Devices Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Abbott Laboratories
• Advanced Bionics AG (Sonova)
• Boston Scientific Corporation
• BrainCo, Inc
• Cochlear Limited
• ElectroCore Inc.
• Helbling Holding AG
• Innovative Health Solutions, Inc.
• LivaNova PLC
• Medtronic
• MicroTransponder
• Neuronetics, Inc.
• Nihon Kohden Corporation
• Natus medical Incorporated
• Parasym Ltd.
• Synapse Biomedical Inc
• tVNS Technologies GmbH (Cerbomed)

Overall world revenue for Neurostimulation Devices Market, 2023 to 2033 in terms of value the market will surpass US$9,000 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Neurostimulation Devices Market, 2023 to 2033 report help you?
In summary, our 250-page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Neurostimulation Devices Market, 2023 to 2033 Market, with forecasts for Type of Product, Type of Application, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 16 key national markets – See forecasts for the Neurostimulation Devices Market, 2023 to 2033 market in North America, Europe, Asia-Pacific and Latin America and Middle East and Africa. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles of the major companies involved in the Neurostimulation Devices Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Neurostimulation Devices Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

❖ レポートの目次 ❖

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Neurostimulation Devices Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increasing Prevalence of Neurological Disorders
3.2.1.2 Growing Investments by Companies and Organizations Across the Globe
3.2.1.3 Technological Advancements in Neurostimulation Devices
3.2.2 Market Restraining Factors
3.2.2.1 Complications Associated with Usage of Neurostimulation Devices
3.2.2.2 Lack of Skilled Healthcare Practitioners
3.2.3 Market Opportunities
3.2.3.1 Rising Demand for Minimally Invasive Surgeries in Developed Countries
3.2.3.2 Increasing Number of Elderly Patients with Neurological Disorders
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis

4 Neurostimulation Devices Market Analysis by Product
4.1 Key Findings
4.2 Product Segment: Market Attractiveness Index
4.3 Neurostimulation Devices Market Size Estimation and Forecast by Product
4.4 Deep Brain Stimulator(DBS)
4.4.1 Market Size by Region, 2023-2033 (US$ Mn)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Gastric Electric Stimulator(GES)
4.5.1 Market Size by Region, 2023-2033 (US$ Mn)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.6 Spinal Cord Stimulator(SCS)
4.6.1 Market Size by Region, 2023-2033 (US$ Mn)
4.6.2 Market Share by Region, 2023 & 2033 (%)
4.7 Sacral Nerve Stimulator
4.7.1 Market Size by Region, 2023-2033 (US$ Mn)
4.7.2 Market Share by Region, 2023 & 2033 (%)
4.8 Vagus Nerve Stimulator
4.8.1 Market Size by Region, 2023-2033 (US$ Mn)
4.8.2 Market Share by Region, 2023 & 2033 (%)
4.9 Transcutaneous Electrical Nerve Stimulation (TENS)
4.9.1 Market Size by Region, 2023-2033 (US$ Mn)
4.9.2 Market Share by Region, 2023 & 2033 (%)
4.10 Others
4.10.1 Market Size by Region, 2023-2033 (US$ Mn)
4.10.2 Market Share by Region, 2023 & 2033 (%)

5 Neurostimulation Devices Market Analysis by Application
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 Neurostimulation Devices Market Size Estimation and Forecast by Application
5.4 Pain Management
5.4.1 Market Size by Region, 2023-2033 (US$ Mn)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Epilepsy
5.5.1 Market Size by Region, 2023-2033 (US$ Mn)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Essential Tremor
5.6.1 Market Size by Region, 2023-2033 (US$ Mn)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Urinary and Fecal Incontinence
5.7.1 Market Size by Region, 2023-2033 (US$ Mn)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Depression
5.8.1 Market Size by Region, 2023-2033 (US$ Mn)
5.8.2 Market Share by Region, 2023 & 2033 (%)
5.9 Dystonia
5.9.1 Market Size by Region, 2023-2033 (US$ Mn)
5.9.2 Market Share by Region, 2023 & 2033 (%)
5.10 Gastroparesis
5.10.1 Market Size by Region, 2023-2033 (US$ Mn)
5.10.2 Market Share by Region, 2023 & 2033 (%)
5.11 Parkinson’s Disease
5.11.1 Market Size by Region, 2023-2033 (US$ Mn)
5.11.2 Market Share by Region, 2023 & 2033 (%)
5.12 Others
5.12.1 Market Size by Region, 2023-2033 (US$ Mn)
5.12.2 Market Share by Region, 2023 & 2033 (%)

6 Neurostimulation Devices Market Analysis by Region
6.1 Key Findings
6.2 Regional Segment: Market Attractiveness Index
6.3 Neurostimulation Devices Market Size Estimation and Forecast

7 North America Neurostimulation Devices Market Analysis
7.1 Key Findings
7.2 North America Neurostimulation Devices Market Attractiveness Index
7.3 North America Neurostimulation Devices Market by Country, 2022, 2027 & 2032 (US$ Mn)
7.4 North America Neurostimulation Devices Market Size Estimation and Forecast by Country
7.5 North America Neurostimulation Devices Market Size Estimation and Forecast by Product
7.6 North America Neurostimulation Devices Market Size Estimation and Forecast by Application
7.7 U.S. Neurostimulation Devices Market Analysis
7.8 Canada Neurostimulation Devices Market Analysis

8 Europe Neurostimulation Devices Market Analysis
8.1 Key Findings
8.2 Europe Neurostimulation Devices Market Attractiveness Index
8.3 Europe Neurostimulation Devices Market by Country, 2022, 2027 & 2032 (US$ Mn)
8.4 Europe Neurostimulation Devices Market Size Estimation and Forecast by Country
8.5 Europe Neurostimulation Devices Market Size Estimation and Forecast by Product
8.6 Europe Neurostimulation Devices Market Size Estimation and Forecast by Application
8.7 Germany Neurostimulation Devices Market Analysis
8.8 France Neurostimulation Devices Market Analysis
8.9 UK Neurostimulation Devices Market Analysis
8.10 Italy Neurostimulation Devices Market Analysis
8.11 Spain Neurostimulation Devices Market Analysis
8.12 Russia Neurostimulation Devices Market Analysis
8.13 Rest of Europe Neurostimulation Devices Market Analysis

9 Asia Pacific Neurostimulation Devices Market Analysis
9.1 Key Findings
9.2 Asia Pacific Neurostimulation Devices Market Attractiveness Index
9.3 Asia Pacific Neurostimulation Devices Market by Country, 2022, 2027 & 2032 (US$ Mn)
9.4 Asia Pacific Neurostimulation Devices Market Size Estimation and Forecast by Country
9.5 Asia Pacific Neurostimulation Devices Market Size Estimation and Forecast by Product
9.6 Asia Pacific Neurostimulation Devices Market Analysis by Application
9.7 Japan Neurostimulation Devices Market Analysis
9.8 China Neurostimulation Devices Market Analysis
9.9 India Neurostimulation Devices Market Analysis
9.10 Australia Neurostimulation Devices Market Analysis
9.11 South Korea Neurostimulation Devices Market Analysis
9.12 Rest of Asia Pacific Neurostimulation Devices Market Analysis

10 Latin America Neurostimulation Devices Market Analysis
10.1 Key Findings
10.2 Latin America Neurostimulation Devices Market Attractiveness Index
10.3 Latin America Neurostimulation Devices Market by Country, 2022, 2027 & 2032 (US$ Mn)
10.4 Latin America Neurostimulation Devices Market Size Estimation and Forecast by Country
10.5 Latin America Neurostimulation Devices Market Size Estimation and Forecast by Product
10.6 Latin America Neurostimulation Devices Market Size Estimation and Forecast by Application
10.7 Brazil Neurostimulation Devices Market Analysis
10.8 Mexico Neurostimulation Devices Market Analysis
10.9 Rest of Latin America Neurostimulation Devices Market Analysis

11 MEA Neurostimulation Devices Market Analysis
11.1 Key Findings
11.2 MEA Neurostimulation Devices Market Attractiveness Index
11.3 MEA Neurostimulation Devices Market by Country, 2022, 2027 & 2032 (US$ Mn)
11.4 MEA Neurostimulation Devices Market Size Estimation and Forecast by Country
11.5 MEA Neurostimulation Devices Market Size Estimation and Forecast by Product
11.6 MEA Neurostimulation Devices Market Size Estimation and Forecast by Application
11.7 GCC Neurostimulation Devices Market Analysis
11.8 South Africa Neurostimulation Devices Market Analysis
11.9 Rest of MEA Neurostimulation Devices Market Analysis

12 Company Profiles
12.1 Competitive Landscape, 2021
12.1.1 Medtronic
12.1.2 Boston Scientific Corporation
12.1.3 Abbott Laboratories
12.1.4 LivaNova PLC
12.2 Abbott Laboratories
12.2.1 Company Snapshot
12.2.2 Company Overview
12.2.3 Financial Analysis
12.2.3.1 Net Revenue, 2017-2021
12.2.3.2 R&D, 2017-2021
12.2.3.3 Regional Market Shares, 2021
12.2.4 Product Benchmarking
12.2.5 Strategic Outlook
12.3 Advanced Bionics AG (Sonova)
12.3.1 Company Snapshot
12.3.2 Company Overview
12.3.3 Product Benchmarking
12.3.4 Strategic Outlook
12.4 Boston Scientific Corporation
12.4.1 Company Snapshot
12.4.2 Company Overview
12.4.3 Financial Analysis
12.4.3.1 Net Revenue, 2017-2021
12.4.3.2 R&D, 2017-2021
12.4.3.3 Regional Market Shares, 2021
12.4.4 Product Benchmarking
12.4.5 Strategic Outlook
12.5 BrainCo, Inc
12.5.1 Company Snapshot
12.5.2 Company Overview
12.5.3 Product Benchmarking
12.5.4 Strategic Outlook
12.6 Cochlear Limited
12.6.1 Company Snapshot
12.6.2 Company Overview
12.6.3 Financial Analysis
12.6.3.1 Net Revenue, 2017-2021
12.6.3.2 R&D, 2017-2021
12.6.3.3 Regional Market Shares, 2021
12.6.4 Product Benchmarking
12.6.5 Strategic Outlook
12.7 ElectroCore Inc
12.7.1 Company Snapshot
12.7.2 Company Overview
12.7.3 Financial Analysis
12.7.3.1 Net Revenue, 2017-2021
12.7.3.2 R&D, 2017-2021
12.7.3.3 Regional Market Shares, 2021
12.7.4 Product Benchmarking
12.7.5 Strategic Outlook
12.8 Helbling Holding AG
12.8.1 Company Snapshot
12.8.2 Company Overview
12.8.3 Financial Analysis
12.8.3.1 Net Revenue, 2017-2021
12.8.4 Product Benchmarking
12.8.5 Strategic Outlook
12.9 Innovative Health Solutions, Inc
12.9.1 Company Snapshot
12.9.2 Company Overview
12.9.3 Product Benchmarking
12.9.4 Strategic Outlook
12.10 LivaNova PLC
12.10.1 Company Snapshot
12.10.2 Company Overview
12.10.3 Financial Analysis
12.10.3.1 Net Revenue, 2017-2021
12.10.3.2 R&D, 2017-2021
12.10.3.3 Regional Market Shares, 2021
12.10.4 Product Benchmarking
12.10.5 Strategic Outlook
12.11 Medtronic
12.11.1 Company Snapshot
12.11.2 Company Overview
12.11.3 Financial Analysis
12.11.3.1 Net Revenue, 2017-2021
12.11.3.2 R&D, 2017-2021
12.11.3.3 Regional Market Shares, 2021
12.11.4 Product Benchmarking
12.11.5 Strategic Outlook
12.12 MicroTransponder
12.12.1 Company Snapshot
12.12.2 Company Overview
12.12.3 Product Benchmarking
12.12.4 Strategic Outlook
12.13 Neuronetics, Inc
12.13.1 Company Snapshot
12.13.2 Company Overview
12.13.3 Financial Analysis
12.13.3.1 Net Revenue, 2017-2021
12.13.3.2 R&D, 2017-2021
12.13.3.3 Regional Market Shares, 2021
12.13.4 Product Benchmarking
12.13.5 Strategic Outlook
12.14 Nihon Kohden Corporation
12.14.1 Company Snapshot
12.14.2 Company Overview
12.14.3 Financial Analysis
12.14.3.1 Net Revenue, 2017-2021
12.14.3.2 R&D, 2017-2021
12.14.3.3 Regional Market Shares, 2021
12.14.4 Product Benchmarking
12.14.5 Strategic Outlook
12.15 Natus Medical Incorporated
12.15.1 Company Snapshot
12.15.2 Company Overview
12.15.3 Product Benchmarking
12.15.4 Strategic Outlook
12.16 Parasym Ltd.
12.16.1 Company Snapshot
12.16.2 Company Overview
12.16.3 Product Benchmarking
12.16.4 Strategic Outlook
12.17 Synapse Biomedical Inc
12.17.1 Company Snapshot
12.17.2 Company Overview
12.17.3 Product Benchmarking
12.17.4 Strategic Outlook
12.18 tVNS Technologies GmbH (Cerbomed)
12.18.1 Company Snapshot
12.18.2 Company Overview
12.18.3 Product Benchmarking
12.18.4 Strategic Outlook

13 Conclusion and Recommendations
13.1 Concluding Remarks from
13.2 Recommendations for Market Players



★調査レポート[世界の神経刺激装置市場2023年～2033年] (コード：VGA23FB013)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の神経刺激装置市場2023年～2033年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のニューロテックデバイス市場2023年～2033年
  • 世界の心血管装置市場2023年～2033年
  • 世界のバイオディフェンス市場2023年～2033年
  • 世界のPoC診断市場2023年～2033年
  • 世界の治験用品市場2023年～2033年
  • 世界の抗生物質市場2023年～2033年
  • 世界のアレルギー性鼻炎薬市場2023年～2033年
  • 世界の髄膜炎菌ワクチン市場2023年～2033年
  • 世界の喘息＆COPD治療市場2023年～2033年

    • ◆H&Iグローバルリサーチのお客様（例）◆